Meeting of the National Advisory Council for Healthcare Research and Quality, 13046-13047 [2019-06417]

Download as PDF 13046 Federal Register / Vol. 84, No. 64 / Wednesday, April 3, 2019 / Notices are divested within two years of acquisition. In order to hold the DPC property beyond the two-year period, a BHC is required to seek the approval of the Board. The two-year period may be extended by the Board for up to three additional years, and holdings in certain types of DPC property may be extended for up to five additional years (for a total of 10 years). Pursuant to section 225.12(b) of Regulation Y, a BHC may request an extension of the section 3(a) holding period for voting securities of a bank or BHC acquired in the ordinary course of collecting a DPC in good faith. Pursuant to section 225.22(d)(1) of Regulation Y, a BHC may request an extension of the section 4(c)(2) holding period for voting securities or assets of a nonbanking company acquired in the ordinary course of collecting a DPC in good faith. The FR 4006 is required to obtain the benefit of being permitted to retain ownership, for more than two years, of voting securities or assets acquired in the ordinary course of collection of a DPC. Individual respondents may request that information submitted to the Board, pursuant to sections 225.12(b) and 225.22(d) of Regulation Y, be kept confidential on a case-by-case basis. Such requests generally contain information related to how the BHC acquired shares or assets and the plans of the BHC to divest the shares or assets. Under certain circumstances, this information may qualify under exemption 4 of the Freedom of Information Act, which protects privileged or confidential commercial or financial information (5 U.S.C. 552(b)(4)). Board of Governors of the Federal Reserve System, March 28, 2019. Michele Taylor Fennell, Assistant Secretary of the Board. [FR Doc. 2019–06434 Filed 4–2–19; 8:45 am] BILLING CODE 6210–01–P GENERAL SERVICES ADMINISTRATION [Notice–WWICC–2019–01; Docket No. 2019– 0003; Sequence No. 1] khammond on DSKBBV9HB2PROD with NOTICES World War One Centennial Commission; Notification of Upcoming Public Advisory Meeting World War One Centennial Commission. ACTION: Meeting notice. AGENCY: Notice of this meeting is being provided according to the requirements of the Federal Advisory Committee Act. This notice provides the schedule and SUMMARY: VerDate Sep<11>2014 17:19 Apr 02, 2019 Jkt 247001 agenda for the May 14, 2019 meeting of the World War One Centennial Commission (the Commission). The meeting is open to the public. DATES: Meeting date: The meeting will be held on Tuesday, May 14, 2019, starting at 9:00 a.m. Central Daylight Time (CDT), and ending no later than 12:00 p.m., CDT. ADDRESSES: The meeting will be held at the National World War I Museum and Memorial, 100 W 26th Street, Kansas City, MO 64108. This location is handicapped accessible. The meeting will be open to the public. Persons attending are requested to refrain from using perfume, cologne, and other fragrances (see http://www.accessboard.gov/about/policies/fragrance.htm for more information). Written Comments may be submitted to the Commission and will be made part of the permanent record of the Commission. Comments must be received by 5:00 p.m. Eastern Daylight Time (EDT), May 10, 2019, and may be provided by email to daniel.dayton@ worldwar1centennial.org. Contact Daniel S. Dayton at daniel.dayton@ worldwar1centennial.org to register to comment during the meeting’s 30minute public comment period. Registered speakers/organizations will be allowed five (5) minutes and will need to provide written copies of their presentations. Requests to comment, together with presentations for the meeting, must be received by 5:00 p.m., EDT, on Friday, May 10, 2019. Please contact Mr. Dayton at the email address above to obtain meeting materials. FOR FURTHER INFORMATION CONTACT: Daniel S. Dayton, Designated Federal Officer, World War 1 Centennial Commission, 701 Pennsylvania Avenue NW, STE 123, Washington, DC 20004– 2608, or via telephone at 202–380–0725 (note: this is not a toll-free number). SUPPLEMENTARY INFORMATION: Background The World War One Centennial Commission was established by Public Law 112–272 (as amended), as a commission to ensure a suitable observance of the centennial of World War I, to provide for the designation of memorials to the service of members of the United States Armed Forces in World War I, and for other purposes. Under this authority, the Committee will plan, develop, and execute programs, projects, and activities to commemorate the centennial of World War I, encourage private organizations and State and local governments to organize and participate in activities commemorating the centennial of World PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 War I, facilitate and coordinate activities throughout the United States relating to the centennial of World War I, serve as a clearinghouse for the collection and dissemination of information about events and plans for the centennial of World War I, and develop recommendations for Congress and the President for commemorating the centennial of World War I. Further, pursuant to Public Law 113– 291 the Commission may enhance the General Pershing Commemorative Work by constructing a World War I Memorial incorporating appropriate sculptural and other commemorative elements, including landscaping, to further honor the service of members of the United States Armed Forces in World War I. Agenda: Tuesday May 14, 2019 Old Business • Approval of Minutes of last meeting New Business • Public Comment Period • Executive Director’s Report—Mr. Daniel Dayton • Financial Report—Commissioner Zoe Dunning • Legislative Update—Mr. Russell Orban • Fundraising Report—Commissioner Tod Sedgwick • International Report—Commissioner Monique Seefried • Memorial Report—Commissioner Edwin Fountain • Education Report—Commissioner Libby O’Connell Other Business • Chairman’s Report—Commissioner Terry Hamby • Other business as may appropriately come before the Commission • Set next meeting—May 12, 2020, Kansas City, MO • Adjourn Dated: March 26, 2019. Daniel S. Dayton, Designated Federal Official, World War I Centennial Commission. [FR Doc. 2019–06278 Filed 4–2–19; 8:45 am] BILLING CODE 6820–95–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Meeting of the National Advisory Council for Healthcare Research and Quality Agency for Healthcare Research and Quality (AHRQ), HHS. AGENCY: E:\FR\FM\03APN1.SGM 03APN1 Federal Register / Vol. 84, No. 64 / Wednesday, April 3, 2019 / Notices ACTION: Notice of public meeting. This notice announces a meeting of the National Advisory Council for Healthcare Research and Quality. SUMMARY: The meeting will be held on Thursday, April 11, 2019, from 11:00 a.m. to 1:00 p.m. (EDT). ADDRESSES: The meeting will be held virtually (via WebEx). FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management Official, at the Agency for Healthcare Research and Quality, 5600 Fishers Lane, Mail Stop 06E37A, Rockville, Maryland, 20857, (301) 427– 1456. For press-related information, please contact Karen Migdail at (301) 427–1855 or Karen.Migdail@ ahrq.hhs.gov. Closed captioning will be provided during the WebEx. If another accommodation for a disability is needed, please contact the Food and Drug Administration (FDA) Office of Equal Employment Opportunity and Diversity Management on (301) 827– 4840, no later than Friday, April 5, 2019. DATES: SUPPLEMENTARY INFORMATION: I. Purpose khammond on DSKBBV9HB2PROD with NOTICES In accordance with section 10(a) of the Federal Advisory Committee Act, 5 U.S.C. App. 2, this notice announces a meeting of the National Advisory Council for Healthcare Research and Quality and is authorized by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director of AHRQ on matters related to AHRQ’s conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members specified in the authorizing legislation. II. Agenda On Thursday, April 11, 2019, the Council meeting will convene via WebEx at 11:00 a.m. (EDT), with the call to order by the Council Chair and approval of previous Council summary VerDate Sep<11>2014 17:19 Apr 02, 2019 Jkt 247001 notes. The agenda will include a presentation on AHRQ Accomplishments, an update on AHRQ’s budget and an update on the Director’s vision for AHRQ. The meeting is open to the public. For information regarding how to access the WebEx as well as other meeting details, please go to https://www.ahrq.gov/news/events/ nac/. Gopal Khanna, Director. [FR Doc. 2019–06417 Filed 4–2–19; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [Document Identifier OS–0990-xxxx] Agency Information Collection Request; 60-Day Public Comment Request Office of the Secretary, HHS. Notice. AGENCY: ACTION: In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment. DATES: Comments on the ICR must be received on or before June 3, 2019. ADDRESSES: Submit your comments to Sherrette.Funn@hhs.gov or by calling (202) 795–7714. FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting information, please include the document identifier 0990–OWH State Level Paid-60D, and project title for reference, to Sherrette Funn, the Reports Clearance Officer, Sherrette.funn@hhs.gov, or call 202– 795–7714. SUPPLEMENTARY INFORMATION: Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. SUMMARY: PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 13047 Title of the Collection: State-Level Paid Family Leave Policy Project. Type of Collection: New. OMB No.: 0990–XXXX or 0990–NEWOffice within OS—Specific program collecting the data (is applicable). Abstract: The Department of Health and Human Services (DHHS) Office on Women’s Health (OWH) ‘‘provides national leadership and coordination to improve the health of women and girls through policy, education, and innovative programs.’’ Through the State-Level Paid Family Leave Policy Project, OWH will explore the relationship between women’s health and state-level paid family leave (PFL) programs, which provide partial wage replacement to eligible employees to bond with a new child. The project aims to increase awareness of women’s health effects in relation to state-level PFL programs among key stakeholders, including advocates, state and federal policymakers, and state program administrators. This information will be used to inform the national conversation about these programs. The State-Level Paid Family Leave Policy Project involves the collection of information on new mothers’ health, health behaviors, and ability to fulfill their roles in the workplace, family and community. Data will be collected through 16 one-time focus groups in the four states with fully functioning statelevel PFL programs (California, New Jersey, Rhode Island, and New York) with both women who used and women who did not use the program. A questionnaire will be administered prior to the focus groups to collect information on participants’ demographic characteristics and other external factors that may affect health. Data collection and analysis will take approximately one year. Interested individuals will be screened for eligibility. Participants must be mothers with a child under the age of one and be eligible for their state’s respective PFL program. To participate as a state-level PFL user, mothers must have used the entire statelevel PFL benefit. To participate as a state-level PFL non-user, mothers must have a baby older than the ‘‘state-level PFL threshold’’ and have not taken any state-level PFL. We define the threshold as the time after which mothers are typically out of the temporary disability insurance (TDI) and state-level PFL window (approximately 12 weeks). E:\FR\FM\03APN1.SGM 03APN1

Agencies

[Federal Register Volume 84, Number 64 (Wednesday, April 3, 2019)]
[Notices]
[Pages 13046-13047]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06417]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Meeting of the National Advisory Council for Healthcare Research 
and Quality

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

[[Page 13047]]


ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting of the National Advisory 
Council for Healthcare Research and Quality.

DATES: The meeting will be held on Thursday, April 11, 2019, from 11:00 
a.m. to 1:00 p.m. (EDT).

ADDRESSES: The meeting will be held virtually (via WebEx).

FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management 
Official, at the Agency for Healthcare Research and Quality, 5600 
Fishers Lane, Mail Stop 06E37A, Rockville, Maryland, 20857, (301) 427-
1456. For press-related information, please contact Karen Migdail at 
(301) 427-1855 or [email protected]. Closed captioning will be 
provided during the WebEx. If another accommodation for a disability is 
needed, please contact the Food and Drug Administration (FDA) Office of 
Equal Employment Opportunity and Diversity Management on (301) 827-
4840, no later than Friday, April 5, 2019.

SUPPLEMENTARY INFORMATION: 

I. Purpose

    In accordance with section 10(a) of the Federal Advisory Committee 
Act, 5 U.S.C. App. 2, this notice announces a meeting of the National 
Advisory Council for Healthcare Research and Quality and is authorized 
by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In 
accordance with its statutory mandate, the Council is to advise the 
Secretary of the Department of Health and Human Services and the 
Director of AHRQ on matters related to AHRQ's conduct of its mission 
including providing guidance on (A) priorities for health care 
research, (B) the field of health care research including training 
needs and information dissemination on health care quality and (C) the 
role of the Agency in light of private sector activity and 
opportunities for public private partnerships. The Council is composed 
of members of the public, appointed by the Secretary, and Federal ex-
officio members specified in the authorizing legislation.

II. Agenda

    On Thursday, April 11, 2019, the Council meeting will convene via 
WebEx at 11:00 a.m. (EDT), with the call to order by the Council Chair 
and approval of previous Council summary notes. The agenda will include 
a presentation on AHRQ Accomplishments, an update on AHRQ's budget and 
an update on the Director's vision for AHRQ. The meeting is open to the 
public. For information regarding how to access the WebEx as well as 
other meeting details, please go to https://www.ahrq.gov/news/events/nac/.

Gopal Khanna,
Director.
[FR Doc. 2019-06417 Filed 4-2-19; 8:45 am]
 BILLING CODE 4160-90-P